WO2000047772A3 - Polymorphic markers of the lsr gene - Google Patents

Polymorphic markers of the lsr gene Download PDF

Info

Publication number
WO2000047772A3
WO2000047772A3 PCT/IB2000/000194 IB0000194W WO0047772A3 WO 2000047772 A3 WO2000047772 A3 WO 2000047772A3 IB 0000194 W IB0000194 W IB 0000194W WO 0047772 A3 WO0047772 A3 WO 0047772A3
Authority
WO
WIPO (PCT)
Prior art keywords
lsr
biallelic
phenotype
provides
biallelic markers
Prior art date
Application number
PCT/IB2000/000194
Other languages
French (fr)
Other versions
WO2000047772A2 (en
Inventor
Marta Blumenfeld
Lydie Bougueleret
Bernard Bihain
Original Assignee
Genset Sa
Marta Blumenfeld
Lydie Bougueleret
Bernard Bihain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset Sa, Marta Blumenfeld, Lydie Bougueleret, Bernard Bihain filed Critical Genset Sa
Priority to EP00903924A priority Critical patent/EP1153139B1/en
Priority to DE60041912T priority patent/DE60041912D1/en
Priority to CA002359757A priority patent/CA2359757A1/en
Priority to AU25674/00A priority patent/AU767378B2/en
Publication of WO2000047772A2 publication Critical patent/WO2000047772A2/en
Publication of WO2000047772A3 publication Critical patent/WO2000047772A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Abstract

The invention provides novel LSR genomic sequences, polypeptides, antibodies, and polynucleotides including biallelic markers derived from the LSR locus. Primers hybridizing to regions flanking these biallelic markers are also provided. This invention also provides polynucleotides and methods suitable for genotyping a nucleic acid containing sample for one or more biallelic markers of the invention. Further, the invention provides methods to detect a statistical correlation between a biallelic marker allele and a phenotype and/or between a biallelic marker haplotype and a phenotype.
PCT/IB2000/000194 1999-02-10 2000-02-08 Polymorphic markers of the lsr gene WO2000047772A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP00903924A EP1153139B1 (en) 1999-02-10 2000-02-08 Polymorphic markers of the lsr gene
DE60041912T DE60041912D1 (en) 1999-02-10 2000-02-08 POLYMORPHE MARKERS OF THE LSR GENE
CA002359757A CA2359757A1 (en) 1999-02-10 2000-02-08 Polymorphic markers of the lsr gene
AU25674/00A AU767378B2 (en) 1999-02-10 2000-02-08 Polymorphic markers of the LSR gene

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11959299P 1999-02-10 1999-02-10
US60/119,592 1999-02-10
US14478499P 1999-07-20 1999-07-20
US60/144,784 1999-07-20

Publications (2)

Publication Number Publication Date
WO2000047772A2 WO2000047772A2 (en) 2000-08-17
WO2000047772A3 true WO2000047772A3 (en) 2000-12-07

Family

ID=26817489

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2000/000194 WO2000047772A2 (en) 1999-02-10 2000-02-08 Polymorphic markers of the lsr gene

Country Status (8)

Country Link
US (2) US6479238B1 (en)
EP (1) EP1153139B1 (en)
AT (1) ATE427362T1 (en)
AU (1) AU767378B2 (en)
CA (1) CA2359757A1 (en)
DE (1) DE60041912D1 (en)
ES (1) ES2323445T3 (en)
WO (1) WO2000047772A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL153927A0 (en) * 2000-07-18 2003-07-31 Genset Sa Genomic maps comprising biallelic markers, new such markers and the use of biallelic markers
US20040210400A1 (en) * 2003-01-27 2004-10-21 Perlegen Sciences, Inc. Analysis methods for individual genotyping
US20050019787A1 (en) * 2003-04-03 2005-01-27 Perlegen Sciences, Inc., A Delaware Corporation Apparatus and methods for analyzing and characterizing nucleic acid sequences
WO2005027719A2 (en) * 2003-09-12 2005-03-31 Perlegen Sciences, Inc. Methods and systems for identifying predisposition to the placebo effect
JP2006288220A (en) * 2005-04-06 2006-10-26 Hitachi High-Technologies Corp Blood test method, nucleic acid recovery method and nucleic acid recovery equipment
AU2006294565A1 (en) * 2005-09-30 2007-04-05 Perlegen Sciences, Inc. Methods and compositions for screening and treatment of disorders of blood glucose regulation
WO2007047913A2 (en) 2005-10-20 2007-04-26 Isis Pharmaceuticals, Inc Compositions and methods for modulation of lmna expression
US20080249103A1 (en) * 2006-11-15 2008-10-09 Sirtris Pharmaceuticals, Inc. Sirtuin polymorphisms and methods of use thereof
WO2009126352A2 (en) * 2008-01-24 2009-10-15 Sandia National Laboratories Novel micropores and methods of making and using thereof
WO2012140627A1 (en) * 2011-04-15 2012-10-18 Compugen Ltd. Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
USD748101S1 (en) * 2013-02-22 2016-01-26 Samsung Electronics Co., Ltd. Graphic user interface for a display screen or a portion thereof
USD745530S1 (en) * 2013-02-22 2015-12-15 Samsung Electronics Co., Ltd. Graphic user interface for a display screen or a portion thereof
CN113136439B (en) * 2021-05-28 2022-04-08 兰州大学 Method for detecting sheep LIPE gene single nucleotide polymorphism and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767136A1 (en) * 1997-08-06 1999-02-12 Genset Sa Use of lipolysis stimulated receptor

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270170A (en) 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
US5691447A (en) 1995-03-24 1997-11-25 Tanox Biosystems, Inc. GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
FR2733762B1 (en) 1995-05-02 1997-08-01 Genset Sa METHOD FOR THE SPECIFIC COUPLING OF THE HAIR OF THE 5 'END OF A RNAM FRAGMENT AND PREPARATION OF RNAM AND COMPLETE DNA
US5869330A (en) 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
JP4018142B2 (en) 1996-01-23 2007-12-05 インデバス ファーマシューティカルズ，インコーポレーテッド Use of obese gene and product thereof to stimulate hematopoiesis
ES2102971B1 (en) 1996-01-25 1998-03-01 Hipra Lab Sa NEW ATTENUATED STRAIN OF THE VIRUS CAUSING THE RESPIRATORY AND REPRODUCTIVE SYNDROME (PRRS), THE VACCINES AND DIAGNOSTIC MEDIA OBTAINABLE WITH THE SAME AND THE PROCEDURES FOR ITS OBTAINING.
US6116126A (en) 1996-07-10 2000-09-12 Van Den Bulcke; Marc Method and machine for making profile pieces
EP0941366A2 (en) 1996-11-06 1999-09-15 Whitehead Institute For Biomedical Research Biallelic markers
FR2767135B1 (en) * 1997-08-06 2002-07-12 Genset Sa LSR COMPLEX RECEPTOR, ACTIVITY, CLONING, AND APPLICATION TO DIAGNOSIS, PREVENTION AND / OR TREATMENT OF OBESITY AND THE RISKS OR COMPLICATIONS THEREOF
WO1999007738A2 (en) 1997-08-06 1999-02-18 Regeneron Pharmaceuticals, Inc. Human orphan receptor ntr-1
US6197930B1 (en) 1997-08-26 2001-03-06 Zymogenetics, Inc. Adipocyte-specific protein homologs
DE69837678T2 (en) 1997-10-29 2007-12-27 Otsuka Pharmaceutical Co., Ltd. COMPOSITION FOR INHIBITING THE PROLIFERATION OF SMOOTH MUSCULATURE AND METHOD FOR THE DIAGNOSIS OF ARTERIOSCLEROSIS

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767136A1 (en) * 1997-08-06 1999-02-12 Genset Sa Use of lipolysis stimulated receptor

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BIHAIN BE ET AL: "The lipolysis-stimulated receptor: a gene at last", CURRENT OPINION IN LIPIDOLOGY,GB,LONDON, vol. 9, no. 3, 1 June 1998 (1998-06-01), pages 221 - 224, XP002096548, ISSN: 0957-9672 *
BIHAIN, B. E. (1) ET AL: "Lipolysis -stimulated receptor: A newcomer on the lipoprotein research scene.", DIABETE & METABOLISME, (1995) VOL. 21, NO. 2, PP. 121-126., XP000925423 *
DUCOBU J: "[Lipoprotein receptors. Old acquaintances and newcomers]. Les recepteurs des lipoproteines. Vieilles connaissances et nouveaux venus.", REVUE MEDICALE DE BRUXELLES, (1997 FEB) 18 (1) 10-5., XP000925412 *
ZHAO L P ET AL: "MAPPING OF COMPLEX TRAITS BY SINGLE-NUCLEOTIDE POLYMORPHISMS", AMERICAN JOURNAL OF HUMAN GENETICS,US,UNIVERSITY OF CHICAGO PRESS, CHICAGO,, vol. 63, no. 1, 1998, pages 225 - 240, XP000920771, ISSN: 0002-9297 *

Also Published As

Publication number Publication date
ATE427362T1 (en) 2009-04-15
AU767378B2 (en) 2003-11-06
EP1153139B1 (en) 2009-04-01
WO2000047772A2 (en) 2000-08-17
AU2567400A (en) 2000-08-29
ES2323445T3 (en) 2009-07-16
US6479238B1 (en) 2002-11-12
DE60041912D1 (en) 2009-05-14
US7125667B2 (en) 2006-10-24
EP1153139A2 (en) 2001-11-14
US20030190636A1 (en) 2003-10-09
CA2359757A1 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
WO2000047771A3 (en) Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism
WO1999032644A3 (en) Prostate cancer gene
Castella et al. Characterization of highly variable microsatellite loci in the bat Myotis myotis (Chiroptera: Vespertilionidae).
WO2000047772A3 (en) Polymorphic markers of the lsr gene
CA2105060A1 (en) Nucleic acid typing by polymerase extension of oligonucleotides using terminator mixtures
CA2396778A1 (en) Methods and kits for identifying elite event gat-zm1 in biological samples
AU3064200A (en) A method of dna sequencing
WO2004023092A3 (en) Genetic analysis and authentication
WO2001000803A3 (en) Apolipoprotein a-iv-related protein: polypeptide, polynucleotide sequences and biallelic markers thereof
CA2348828A1 (en) Genomic and complete cdna sequences of apm1 and biallelic markers thereof
WO2001051659A3 (en) Biallelic markers derived from genomic regions carrying genes involved in central nervous system disorders
WO2001066800A8 (en) Human single nucleotide polymorphisms
WO2000058508A3 (en) Biallelic markers related to genes involved in drug metabolism
EP1069189A3 (en) Genotyping biallelic markers
WO1999050454A3 (en) Coding sequence polymorphisms in vascular pathology genes
AU2038500A (en) Method for the detection of specific nucleic acid sequences by polymerase nucleotide incorporation
WO2003031641A3 (en) Beta 2 adrenergic polymorphism detection
WO2001042511A3 (en) Ibd-related polymorphisms
EP0967282A3 (en) Cytochrome bd type quinol oxidase gene of Brevibacterium lactofermentum
WO2002006525A3 (en) Obesity associated biallelic marker maps
EP0787806A3 (en) Abo glycosyltransferase sequence polymorphism
CA2289961A1 (en) A gene causative of rheumatoid arthritis, method for diagnosing rheumatoid arthritis, and method for identifying causative factors of rheumatoid arthritis
WO2001038576A3 (en) Human single nucleotide polymorphisms
WO2003023063A1 (en) Method of judging onset risk of diabetes
WO2003042226A3 (en) Single nucleotide polymorphisms in gh-1

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2359757

Country of ref document: CA

Ref country code: CA

Ref document number: 2359757

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 25674/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000903924

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000903924

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 25674/00

Country of ref document: AU